ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2014

Aug 13, 2014

SEC Form 4/A — Form 4/A

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2014-08-12

Reporting Person: Bencich John (CFO and PFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-12	Stock Option (right to buy)	$3.17	A	40000	Acquired	2024-08-12	Common (40000)	Direct
2014-08-12	Restricted Stock Unit (RSU)	$	A	20000	Acquired		Common (20000)	Direct

Footnotes

F1: This amended Form 4 is filed to correct (a) the exercise price, which was inadvertently reported as $3.30, (b) the transaction date, which was inadvertently reported as August 11, 2014 and (c) the expiration date, which was inadvertently reported as August 11, 2024.

F2: This amended Form 4 is filed to correct the exercisable date. The options vest monthly over 48 months, commencing on September 12, 2014, which was inadvertently reported as September 11, 2014.

F3: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.

F4: This amended Form 4 is filed to correct the exercisable date. Twenty-five percent of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 12, 2014, which was inadvertently reported as August 11, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.

F5: The RSUs expire 30 days from the date they vest.